Seasoned Leader Jim Kean Takes the Helm as CEO of Molecular You for US Expansion
18 juil. 2023 09h34 HE
|
Molecular You Corporation
VANCOUVER, British Columbia, July 18, 2023 (GLOBE NEWSWIRE) -- Molecular You is thrilled to announce the appointment of Jim Kean as CEO to spearhead the company's expansion efforts in the United...
Molecular You launches a new preventive solution shown to improve health outcomes over 100 days
10 janv. 2023 08h38 HE
|
Molecular You Corporation
VANCOUVER, British Columbia, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Molecular You announced the launch of its preventive digital health solution, based on a new type of blood test that leverages their...
Fountain Health Announces Full Coverage on Neurological Imaging
15 nov. 2022 09h00 HE
|
Fountain Health Insurance
NAPLES, Fla., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Fountain Health is proud to officially announce 100 percent coverage of Combinostics cMRI™ and cDSI™ — the industry-leading AI-enabled neurological...
GoodCell Adds HSA Bank to its Network, Expanding the Company’s Targeted Reach to HSA & FSA Account Holders
02 nov. 2022 07h30 HE
|
GoodCell
Norwalk, CT, Nov. 02, 2022 (GLOBE NEWSWIRE) -- GoodCell, a life sciences company, added HSA Bank, a division of Webster Bank, N.A., to its growing network comprised of benefits administrators,...
GoodCell Launches in Concierge Practices to Meet the Demand for Proactive & Preventative Longevity Services
20 oct. 2022 07h30 HE
|
GoodCell
Atlanta, GA, Oct. 20, 2022 (GLOBE NEWSWIRE) -- At Concierge Medicine Today’s annual Forum, GoodCell, a life sciences company, launched its Personal Biobanking service in concierge medicine practices...
GoodCell Launches “On-The-Go” Delivering Turnkey, Onsite Onboarding for 2022 Open Enrollment Season
03 oct. 2022 07h30 HE
|
GoodCell
Norwalk, CT, Oct. 03, 2022 (GLOBE NEWSWIRE) -- GoodCell, a medically-actionable service to identify, track and manage chronic diseases and conditions impacting millions of Americans, today launched...
Life Line Screening accelerates its clinical research transformation by appointing Matthew Maxwell as Chief of Clinical Research Strategy.
29 janv. 2021 07h00 HE
|
Life Line Screening
Mr. Maxwell will be responsible for unlocking Life Line Screening’s distinctive ability to connect motivated patients to compelling clinical research opportunities. AUSTIN, Texas, Jan. 29, 2021 ...
PreveCeutical™ Medical Inc. Announces Preliminary Results from Phase One of its Venom Re-Engineering Project
11 août 2017 03h05 HE
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, Aug. 11, 2017 (GLOBE NEWSWIRE) -- PreveCeutical™ Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (FSE:18H) announces encouraging results from the Research and...
PreveCeutical™ Medical Inc. Signs Letter of Intent with UniQuest Pty Limited for Research & Development Program Engineering Peptide Therapeutics for Non-Addictive Analgesics
08 août 2017 03h05 HE
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, Aug. 08, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (FSE:18H) announces that on August 7, 2017, the Company signed...
PreveCeutical™ Medical Inc. Begins Trading on the Frankfurt Stock Exchange
01 août 2017 08h30 HE
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, Aug. 01, 2017 (GLOBE NEWSWIRE) -- PreveCeutical™ Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) announces the listing of its common shares for trading on the...